Vaccine for HPV type 16 in women with mild cervical changes
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This trial tests an experimental vaccine for women who have HPV type 16 but only mild or no precancerous changes (CIN1 or less). The vaccine uses a special device to help your body's immune system fight the virus, which may prevent it from becoming cervical cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You test positive for HPV type 16, and your cervical biopsy shows CIN1 or less (mild or no precancerous changes).
- You are 19 years or older.
- Your blood counts and liver/kidney function are within acceptable ranges.
- You have not been treated for HPV before with topical agents or surgical procedures like LEEP or cone biopsy.
- You are not pregnant or breastfeeding and will use effective birth control during the study.
- You have enough muscle at the injection sites (upper thigh or upper arm) to receive the vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new vaccine (pBI-11) given with a device that uses mild electric pulses to help the vaccine enter cells. It is for people who have HPV16 or 18 but no high-grade cervical changes.
This study tests an experimental vaccine (RG002) for women with cervical pre-cancer caused by HPV types 16 or 18. The vaccine is designed to help the body fight the virus and potentially clear the pre-cancerous cells, possibly avoiding more invasive treatments.
This trial tests a new vaccine called PVX4 for women with HPV16-related cervical dysplasia. It aims to see if the vaccine can help clear the high-risk HPV infection and the abnormal cells on the cervix.
This Phase 1 study tests FluBHPVE6E7, a new treatment designed to help the immune system respond to HPV16. It mainly checks safety and the best dose, and may help your body clear or control HPV over time.
This early-phase study tests a vaccine designed to help your immune system fight HPV16, a type of human papillomavirus linked to abnormal cells in the cervix. You may or may not be living with HIV, and the team will check safety and immune response after giving the vaccine in a specific way.
This trial tests a new vaccine called RG1-VLP that may help prevent cancers caused by HPV. It is for healthy women who have not had an HPV vaccine before and are willing to follow study procedures.
Hear when a new Cervical Intraepithelial Neoplasia Grade 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.